S M T W T F S
 
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
 
 
 
 
 
 
 
 
 
 
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
 
 

Kane Biotech – Q3 2017 Financial Results, Resignation of Director and Granting of Options

DATE POSTED:November 14, 2017

WINNIPEG, Manitoba, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) is pleased to announce its Q3 2017 Financial Results.